1. Surgical sexism in Canada: structural bias in reimbursement of surgical care for women.
- Author
-
Chaikof M, Cundiff GW, Mohtashami F, Millman A, Larouche M, Pierce M, Brennand EA, and McDermott C
- Subjects
- Pregnancy, Humans, Male, Female, Canada, Sexism, Surgeons
- Abstract
Background: It is well established that female physicians in Canada are reimbursed at lower rates than their male counterparts. To explore if a similar discrepancy exists in reimbursement for care provided to female and male patients, we addressed this question: Do Canadian provincial health insurers reimburse physicians at lower rates for surgical care provided to female patients than for similar care provided to male patients?, Methods: Using a modified Delphi process, we generated a list of procedures performed on female patients, which we paired with equivalent procedures performed on male patients. We then collected data from provincial fee schedules for comparison., Results: In 8 out of 11 Canadian provinces and territories studied, we found that surgeons were reimbursed at significantly lower rates (28.1% [standard deviation 11.1%]) for procedures performed on female patients than for similar procedures performed on male patients., Conclusion: The lower reimbursement of the surgical care of female patients than for similar care provided to male patients represents double discrimination against both female physicians and their female patients, as female providers predominate in obstetrics and gynecology. We hope our analysis will catalyze recognition and meaningful change to address this systematic inequity, which both disadvantages female physicians and threatens the quality of care for Canadian women., Competing Interests: Competing interests: G. Cundiff has received book royalties from Wolters Kluwer and honoraria from AbbVie. He is the chief medical officer for Amara Therapeutics and has a patent pending with this company. F. Mohtashami has received educational grants from Medtronic, Hologic and Boston Scientific. E. Brennand has received speaking fees from Searchlight Pharma. C. McDermott is a medical advisor for Szio+ and COSM and has stocks or stock options in these companies. She is also a speaker for Pfizer., (© 2023 CMA Impact Inc. or its licensors.)
- Published
- 2023
- Full Text
- View/download PDF